Triple-negative breast cancer (TNBC) is a subtype defined by lacking estrogen receptor, progesterone receptor expression, and human epidermal growth factor receptor 2 (HER2) overexpression/amplification [2], which constitutes 10% to 20% of all breast cancers [3]. Here, ERBB2 is linked to breast carcinoma.